The Patent Finder
US

Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders

US 11,072,611 In force
OverviewFamilyAssignmentsSources & methods

Term ends Mar 12, 2034 · High confidence

Filed Nov 13, 2019 as application 16/682,553 · Granted Jul 27, 2021
Base term, 20 years from filing
Today
20 years from filing
2014 2034
Clock starts
Mar 12, 2014
Term ends
Mar 12, 2034
Granted
Jul 27, 2021
base term fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,125,132, US 8,993,590, US 9,670,204, to Mar 12, 2034. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 12, 2014, when application 14/205,885, the earliest non-provisional in its chain, was filed (this one was filed Nov 13, 2019)Mar 12, 2034High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,125,132, US 8,993,590, US 9,670,204)resolves to Mar 12, 2034, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMar 12, 2034High confidence

This family

US 8,993,590In force
Mar 2034
Mar 2034
US 9,249,141In force
Mar 2034
Mar 2034
US 9,670,204Lapsed on the fee record
Jun 2025
Jun 2025
US 10,125,132In force
Mar 2034
Mar 2034
US 10,526,329In force
Mar 2034
Mar 2034
US 11,072,611this patent
Mar 2034
Mar 2034
Application 17/351,765Abandoned
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 13, 2019
Reel 50999, frame 215
Brys, Reginald Christophe Xavier; Desroy, Nicolas; Heckmann, Bertrand; Joncour, Agnes Marie; Peixoto, Christophe; Bock, Xavier Marie; Galapagos SasuGalapagos N.V.Assignment of Assignor's Interest
Jun 4, 2026
Reel 74845, frame 68
GalapagosLakefront BiotherapeuticsChange of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited